Market Update: Stocks Near Record Highs, Novo Nordisk Soars on FDA Approval
Stocks remained close to their record levels on Tuesday, with the S&P 500 just below its all-time high. The Dow Jones Industrial Average and the Nasdaq composite also saw slight gains. While most S&P 500 stocks were down, big technology companies like Nvidia and Alphabet helped boost the market.
Novo Nordisk saw a significant jump in its stock price after U.S. regulators approved a pill version of the weight-loss drug Wegovy. The economic updates during this holiday-shortened week have shown that the U.S. economy grew at a 4.3% annual rate in the third quarter, with inflation remaining high.
The Federal Reserve's preferred inflation gauge, the PCE index, rose to a 2.8% annual pace in the last quarter. The central bank has been cautious in its policy approach due to mixed economic signals, including strong economic growth and high inflation. Consumer confidence has also been affected by concerns about high prices and a slowing job market.
Despite worries about high prices and a trade war, consumer spending and confidence have been shaky. The latest data from The Conference Board showed a decline in consumer confidence in December, while retail sales have been weakening. Consumers have been more selective in their holiday shopping this season, with cash and credit card sales rising less than in the previous year.
Overall, markets in Asia and Europe showed mixed results, reflecting the uncertainty in the global economy. The upcoming Fed meeting in January will be closely watched for any changes in interest rates as the central bank navigates the challenges of high inflation and slowing economic growth.